JP2005501061A5 - - Google Patents

Download PDF

Info

Publication number
JP2005501061A5
JP2005501061A5 JP2003518452A JP2003518452A JP2005501061A5 JP 2005501061 A5 JP2005501061 A5 JP 2005501061A5 JP 2003518452 A JP2003518452 A JP 2003518452A JP 2003518452 A JP2003518452 A JP 2003518452A JP 2005501061 A5 JP2005501061 A5 JP 2005501061A5
Authority
JP
Japan
Prior art keywords
nutritional supplement
sod
group
support component
component
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003518452A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005501061A (ja
Filing date
Publication date
Priority claimed from US09/927,174 external-priority patent/US6503506B1/en
Application filed filed Critical
Publication of JP2005501061A publication Critical patent/JP2005501061A/ja
Publication of JP2005501061A5 publication Critical patent/JP2005501061A5/ja
Pending legal-status Critical Current

Links

JP2003518452A 2001-08-10 2002-08-09 免疫機能損傷患者の為の栄養療法 Pending JP2005501061A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/927,174 US6503506B1 (en) 2001-08-10 2001-08-10 Nutrient therapy for immuno-compromised patients
PCT/US2002/025358 WO2003013438A2 (en) 2001-08-10 2002-08-09 Nutrient therapy for immuno-compromised patients

Publications (2)

Publication Number Publication Date
JP2005501061A JP2005501061A (ja) 2005-01-13
JP2005501061A5 true JP2005501061A5 (enExample) 2006-01-05

Family

ID=25454328

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003518452A Pending JP2005501061A (ja) 2001-08-10 2002-08-09 免疫機能損傷患者の為の栄養療法

Country Status (9)

Country Link
US (1) US6503506B1 (enExample)
EP (1) EP1432436A4 (enExample)
JP (1) JP2005501061A (enExample)
CN (1) CN1568196A (enExample)
AP (1) AP2004002994A0 (enExample)
CA (1) CA2457624A1 (enExample)
EA (1) EA006439B1 (enExample)
OA (1) OA12649A (enExample)
WO (1) WO2003013438A2 (enExample)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6616942B1 (en) 1999-03-29 2003-09-09 Soft Gel Technologies, Inc. Coenzyme Q10 formulation and process methodology for soft gel capsules manufacturing
FR2822704B1 (fr) * 2001-03-29 2005-02-18 Chiesi Sa Sels de cetoacides et d'acides amines gastroresistants et leur utilisation pour la preparation de medicaments
US6503506B1 (en) * 2001-08-10 2003-01-07 Millenium Biotechnologies, Inc. Nutrient therapy for immuno-compromised patients
US20080089877A1 (en) * 2003-08-14 2008-04-17 Udell Ronald G Super Absorption Coenzyme Q10
US7169385B2 (en) * 2003-09-29 2007-01-30 Ronald G. Udell Solubilized CoQ-10 and carnitine
US8124072B2 (en) 2003-09-29 2012-02-28 Soft Gel Technologies, Inc. Solubilized CoQ-10
AU2004277951B2 (en) 2003-09-29 2010-11-11 Soft Gel Technologies, Inc. Solubilized CoQ-10
ITTO20030789A1 (it) 2003-10-07 2005-04-08 Professional Dietetics Srl Composizione a base di amino acidi per il trattamento
EP1675480B1 (en) * 2003-10-16 2018-06-13 Nestec S.A. Nutritional composition against side effects of chemotherapy of radiotherapy
EP1718283B1 (en) 2004-01-22 2013-03-06 University of Miami Topical co-enzyme q10 formulations and methods of use
JP2007519678A (ja) * 2004-01-28 2007-07-19 ネステク ソシエテ アノニム 皮膚状態を改良しそして皮膚病を予防するための栄養組成物
US20050209170A1 (en) * 2004-03-18 2005-09-22 Takemoto Arnold C Breast health preparations
AU2005223618A1 (en) * 2004-03-17 2005-09-29 Arnold C. Takemoto Tissue detoxification and health supplements and methods of making and using them
JP2005336176A (ja) * 2004-04-28 2005-12-08 Tanabe Seiyaku Co Ltd 肉体疲労改善剤
EP1600061B1 (en) * 2004-05-25 2010-05-12 Cognis IP Management GmbH Oral and/or topical compositions
US20050265990A1 (en) * 2004-06-01 2005-12-01 Shawn Talbott Treatments and nutritional supplements for assisting post-exercise recovery
NZ552908A (en) * 2004-06-30 2009-11-27 Atsuo Sekiyama Indicator agent for noninflammatory stress response and use thereof
KR100584891B1 (ko) 2004-08-13 2006-05-30 (주)씨스팜 경구용 슈퍼옥사이드 디스뮤타제 제제인, 캔털루프 멜론추출물과 글리아딘 결합물을 숙취해소에 사용하는 방법
US7284385B2 (en) * 2004-09-16 2007-10-23 Hess Spencer W Pre-dried air reactivation for diesel fuel heated dessicant reactivator
JP5040060B2 (ja) * 2004-10-14 2012-10-03 大正製薬株式会社 メチオニン配合内服液剤
US20060147550A1 (en) * 2004-12-30 2006-07-06 Gorsek Wayne F Immune system enhancement and stimulation formulation
WO2008136793A1 (en) 2007-05-03 2008-11-13 Williams Christopher P Low radiocarbon dietary supplements and methods of making same
US20070114476A1 (en) * 2005-11-04 2007-05-24 Williams Christopher P Low radiocarbon nucleotide and amino acid dietary supplements
CN101316582A (zh) * 2005-11-30 2008-12-03 雀巢技术公司 治疗肌肉损失的方法
WO2007077995A1 (ja) * 2006-01-05 2007-07-12 Kyowa Hakko Kogyo Co., Ltd. 筋肉増量剤
GB0603975D0 (en) * 2006-03-01 2006-04-05 Etren Methods and agents for reducing oxidative stress
CA2645674A1 (en) * 2006-03-15 2007-09-20 Isocell Pharma S.A. Pharmaceutical compositions comprising sods and prolamine based peptide fragments
FR2899065B1 (fr) * 2006-03-29 2008-07-18 Alain Dreyer Brevets Et Dev So Sod micro encapsulee et adsorbee sur support mineral et vegetal destinee a l'alimentation animale
DE102006046960A1 (de) * 2006-10-04 2008-04-10 Euro Allianz Pharma Gmbh Gesundheitsfördernde Nahrungsmittelzusammensetzung
US20080119386A1 (en) * 2006-11-22 2008-05-22 Carl Germano Nutritional formula for athletes' recovery
US8343541B2 (en) 2007-03-15 2013-01-01 Soft Gel Technologies, Inc. Ubiquinol and alpha lipoic acid compositions
CN102309503B (zh) * 2007-09-27 2013-11-20 生物高聚物工程公司Dba生物治疗公司 β-葡聚糖用于上呼吸道感染症状和心理健康
WO2009099444A1 (en) * 2008-02-08 2009-08-13 Millennium Biotechnologies, Inc. Nutritional formula for athletes' recovery
WO2009126764A1 (en) 2008-04-11 2009-10-15 Cytotech Labs, Llc Methods and use of inducing apoptosis in cancer cells
US8865733B2 (en) * 2008-11-06 2014-10-21 Altman Enterprises, LLC Medication and treatment for disease
CN102482713B (zh) 2009-05-11 2017-06-30 博格有限责任公司 利用表观代谢转变剂、多维细胞内分子或环境影响剂诊断肿瘤障碍的方法
EP2311449A1 (de) * 2009-10-14 2011-04-20 NÖM Aktiengesellschaft Oral verabreichbare nahrungsergänzende Zusammensetzung enthaltend Carnitin
DK3372228T3 (da) * 2010-12-23 2025-05-26 Amazentis Sa Ikke-terapeutisk fremgangsmåde til at øge eller opretholde mitokondriefunktion
WO2012097061A1 (en) * 2011-01-13 2012-07-19 Abbott Laboratories Nutritional compositions and methods for improving skeletal muscle protein metabolism
WO2012099980A2 (en) * 2011-01-18 2012-07-26 Equine Nutriceuticals, Llc Equine nutritional supplement
WO2012138765A1 (en) 2011-04-04 2012-10-11 Berg Pharma Llc Methods of treating central nervous system tumors
EA032775B1 (ru) 2013-04-08 2019-07-31 Берг Ллк Способы лечения злокачественной опухоли с использованием комбинированной терапии с коферментом q10
EP3041496B1 (en) 2013-09-04 2020-04-29 Berg LLC Methods of treatment of cancer by continuous infusion of coenzyme q10
US20170189350A1 (en) 2015-11-16 2017-07-06 Berg Llc Methods of treatment of temozolomide-resistant glioma using coenzyme q10
CN105709212A (zh) * 2016-01-29 2016-06-29 周瑞华 一种免疫平衡调节剂及其制备方法和应用
RU2656544C1 (ru) * 2017-07-07 2018-06-05 Общество с ограниченной ответственностью "Академия-Т" Функциональный продукт питания для коррекции психофизиологического состояния и нейромышечной передачи у спортсменов
WO2020033874A1 (en) * 2018-08-10 2020-02-13 Maine Natural Health Company, Inc. Comestible compositions for promoting atp synthesis
CN110664824B (zh) * 2019-08-09 2021-01-01 北京佳博泰和健康科技有限公司 一种营养支持剂及其制备方法和用途
CN111820330A (zh) * 2020-07-17 2020-10-27 禹城保立康生物饲料有限公司 一种提高哺乳仔猪发育的母猪饲料

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5456924A (en) * 1988-12-23 1995-10-10 Immunotec Research Corporation Ltd. Method of treatment of HIV-seropositive individuals with dietary whey proteins
IT1258491B (it) * 1992-09-24 1996-02-26 Sigma Tau Ind Farmaceuti Impiego di l-carnitina e acil l-carnitine nel trattamento di pazienti affetti da aids e sindromi correlate e di pazienti asintomatici hiv- sieropositivi.
FR2729296B1 (fr) 1995-01-12 1997-03-28 Europlanaire Compositions pharmaceutiques comprenant une superoxyde dismutase
US5817329A (en) * 1997-02-28 1998-10-06 Gardiner; Paul T. Nutritional supplement for increased muscle size and strength for body builders
US6503506B1 (en) * 2001-08-10 2003-01-07 Millenium Biotechnologies, Inc. Nutrient therapy for immuno-compromised patients

Similar Documents

Publication Publication Date Title
JP2005501061A5 (enExample)
RU2633071C2 (ru) Препарат для применения аспартата и витамина в12 или биотина для регуляции кетоновых тел
JP2006510711A5 (enExample)
ES2569922T3 (es) Composiciones nutritivas, que incluyen un componente de alto contenido en proteínas y nucleótidos exógenos
WO2003013438A3 (en) Nutrient therapy for immuno-compromised patients
US20040071825A1 (en) Agglomerated granular protein-rich nutritional supplement
US11412768B2 (en) Method of improving tolerance to hypoallergenic infant formulas
JP2007519678A (ja) 皮膚状態を改良しそして皮膚病を予防するための栄養組成物
US9144592B2 (en) Dietary supplement with protein activator
JP2002065212A (ja) 筋強化用食品組成物及び筋強化剤
Martínez Augustín et al. Arginina, óxido nítrico y función endotelial
Klatz The Official Anti-Aging Revolution: Stop the Clock Time is on Your Side for a Younger, Stronger, Happier You
AU2002358347B2 (en) Modified methionine rich food products and process for their manufacture
WO2022177516A1 (en) Nutritional powder compositions for promoting wound healing
WO2017146561A1 (es) Suplemento dietético para mejorar la fijación de nutrimento e incrementar la masa muscular
HK1146373B (en) Method for decreasing bitterness and improving taste of protein-free and hydrolyzed infant formulas